In silico studies on the therapeutic potential of novel marker compounds isolated from chemically modified bioactive fraction from Curcuma longa (Non-carbonyl Curcuma longa)

Arshi Naqvi; Reem A K. Al-Harbi; Samah Ali; Richa Malasoni; Swati Gupta; Anil Kumar Dwivedi

Articles

Abstract

Pharmacognosy Magazine,2021,17,74,263-267.

DOI:10.4103/pm.pm_317_20

Published:July 2021

Type:Original Article

Authors:

Author(s) affiliations:

Arshi Naqvi¹, Reem A K. Al-Harbi², Samah Ali³, Richa Malasoni⁴, Swati Gupta⁴, Anil Kumar Dwivedi⁴
¹ Department of Chemistry, College of Science, Taibah University, Al-Madina Al-Munawwara, Saudi Arabia; Pharmaceutics Division, CSIR-Central Drug Research Institute, Lucknow, Uttar Pradesh, India
² Department of Chemistry, College of Science, Taibah University, Al-Madina Al-Munawwara, Saudi Arabia
³ Department of Chemistry, College of Science, Taibah University, Al-Madina Al-Munawwara, Saudi Arabia; Vitamins, The National Organization for Drug Control and Research, Al-Agouzah, Giza, Egypt
⁴ Pharmaceutics Division, CSIR-Central Drug Research Institute, Lucknow, Uttar Pradesh, India

Abstract:

Background: Curcuma longa, a perennial herb, is a member of the Zingiberaceae (ginger) family is described to possess a broad spectrum of biological activities. Herbal medicament (HM) or curcuma oil is a bioactive standardized hexane-soluble fraction of C. longa and is established for its neuroprotective effect. HM was modified chemically to unfasten compounds containing carbonyl group in it resulting in a bioactive non-carbonyl C. longa (NCCL). Objectives: In the present study, novel marker compounds (A and B) have been successfully isolated from NCCL and their various in silico traits and interactions were studied. Materials and Methods: Marker compounds A and B were characterized utilizing various spectroscopic data (one-dimensional [1D]/2D Nuclear Magnetic Resonance (NMR), mass spectrometry, and infrared). Isolated compounds were subjected to in silico computational tools for predicting their drug-likeness, pharmacokinetic, pharmacodynamic properties. Results: Both compounds A and B flaunted drug-like properties by following the standard descriptors along with good in silico absorption. Conclusion: Novel marker compounds A and B were successfully isolated from NCCL and fully characterized utilizing spectroscopic techniques. Both the compounds displayed good drug-like properties.